After Carl Hansen co-founded AbCellera Biologics Ltd. in 2012, people constantly told him he was…
eabramovichJanuary 13, 2021
A pilot study has shown that an experimental vaccine for cat allergy can reduce the…
eabramovichJanuary 11, 2021
Have you ever wondered how your body knows to respond to an infection appropriately? When…
eabramovichJanuary 11, 2021
Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce that it is…
eabramovichJanuary 8, 2021
A Burnaby biotech company is partnering with a global pharmaceutical giant on research into advancing…
eabramovichJanuary 7, 2021
iCo Therapeutics (“iCo” or the “Company”) (TSX-V: ICO) (OTCQB: ICOTF), iCo Therapeutics, Inc. (“iCo”) and…
eabramovichJanuary 6, 2021
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225,…
eabramovichDecember 18, 2020
This year marks the 20th anniversary of the founding of Genome BC, the genomics research organization…
eabramovichDecember 17, 2020
Share prices of AbCellera Biologics Inc. (Nasdaq:ABCL) nearly tripled over the course of their first…
eabramovichDecember 16, 2020
